$540.030
+6.318 (+1.17%)收盤時
價格預測
在 App 中開啟以解鎖更長週期的預測。
MDGL 相似圖表分析預測
Alphio's MDGL stock price prediction model matches the current Madrigal Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $533.86 (-0.90%). The 1-week path is $529.82 (-1.65%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
該買進 Madrigal Pharmaceuticals Inc 股票嗎？
Madrigal Pharmaceuticals Inc is a good buy right now due to its strong sales growth momentum, with Rezdiffra achieving $364.3 million in Q2 sales, reflecting a 71% year-over-year increase. Additionally, the current price of $533.76 is significantly below the analyst price targets, which range from $605 to $962, indicating substantial upside potential. The main risk is the forward P/E ratio of 666.67, suggesting high expectations that may not be met if growth slows.
MDGL 股價於 Monday 收在 $540.03，此前上漲 +1.17%
Madrigal Pharmaceuticals Inc (MDGL) last closed at $538.71, losing -0.24%. These facts feed the 1-day and 1-week MDGL price prediction above.
分析師一致預期
Madrigal Pharmaceuticals Inc（MDGL）：買進 3、持有 0、賣出 0。展望：Strong Buy。
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
預測驅動因素
Madrigal Pharmaceuticals Inc（MDGL）的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
相似圖表形態
近期走勢與 MDGL 最接近的股票，依相似度排序。
MDGL 季節性分析
Historically the probability of a positive September return for MDGL is 83.33%. November offers the highest probability of a positive month at 100.00%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。